Sclerostin regulation: a promising therapy for periodontitis by modulating alveolar bone
Abstract. Periodontitis is one of the most prevalent epidemics affecting human health and life recently, and exploration of the pathogenesis and treatment of periodontitis has been valued by scholars. In recent years, sclerostin, a new factor on bone resorption and reconstruction caused by inflammat...
Main Authors: | Tian-Jiao Li, Rui Wang, Qin-Yang Li, Chun-Yu Li, Li Jiang, Li-Shao Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-06-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000000764 |
Similar Items
-
Expression of sclerostin in alveolar bone remodeling of ovariectomized rats
by: GUO Ying, et al.
Published: (2020-12-01) -
Sclerostin Modulation Holds Promise for Dental Indications
by: Mohamed G. Hassan, et al.
Published: (2018-11-01) -
Sclerostin and its role in the regulation of bone metabolism
by: Irina Stepanovna Dydykina, et al.
Published: (2013-06-01) -
The roles of osteocytes in alveolar bone destruction in periodontitis
by: Xiaofei Huang, et al.
Published: (2020-12-01) -
Is sclerostin antibody an effective agent for alveolar bone regeneration in animal models? A scoping review
by: Venkitachalam Ramanarayanan, et al.
Published: (2022-12-01)